Who owns BeOne Medicines Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ONC from SEC Form 13F filings across 323 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 323 institutions disclosed 36.7M shares of BeOne Medicines Ltd. worth $13.40B — about 32.3% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
323
13F holders
$13.40B
value, 2026 filers
32.3%
of shares outstanding (36.7M sh)
70
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ONC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 8.8M | $3.23B | 15.4% | 7.8% | +0.3% |
| 2 | PRIMECAP MANAGEMENT CO/CA/ | 4.9M | $1.80B | 1.1% | 4.3% | -2.0% |
| 3 | Capital International Investors | 4.6M | $1.69B | 0.3% | 4.1% | +9.5% |
| 4 | Capital World Investors | 3.9M | $1.43B | 0.2% | 3.4% | +73.5% |
| 5 | FMR LLC | 2.3M | $849.7M | 0.0% | 2% | -6.3% |
| 6 | BlackRock, Inc. | 804,086 | $294.2M | 0.0% | 0.7% | +15.8% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 737,045 | $269.7M | 0.0% | 0.6% | -2.9% |
| 8 | MORGAN STANLEY | 665,264 | $243.4M | 0.0% | 0.6% | +33.7% |
| 9 | TWO SIGMA INVESTMENTS, LP | 656,706 | $240.3M | 0.2% | 0.6% | +129.2% |
| 10 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 553,389 | $202.5M | 0.1% | 0.5% | +121.6% |
| 11 | CITADEL ADVISORS LLC | 520,094 | $190.3M | 0.0% | 0.5% | -63.5% |
| 12 | Man Group plc | 492,820 | $180.3M | 0.3% | 0.4% | +60.3% |
| 13 | Siren, L.L.C. | 465,000 | $170.2M | 4.0% | 0.4% | 0.0% |
| 14 | BANK OF AMERICA CORP /DE/ | 439,177 | $160.7M | 0.0% | 0.4% | 0.0% |
| 15 | Baird Financial Group, Inc. | 354,126 | $129.6M | 0.2% | 0.3% | -4.0% |
| 16 | FIRST TRUST ADVISORS LP | 312,985 | $114.5M | 0.1% | 0.3% | +27.3% |
| 17 | Capital International, Inc./CA/ | 290,164 | $106.2M | 0.8% | 0.3% | -5.0% |
| 18 | Candriam S.C.A. | 289,235 | $106.2M | 0.5% | 0.3% | -0.2% |
| 19 | BNP PARIBAS FINANCIAL MARKETS | 286,359 | $104.8M | 0.0% | 0.3% | +54.3% |
| 20 | MILLENNIUM MANAGEMENT LLC | 278,720 | $102.0M | 0.0% | 0.2% | -48.7% |
| 21 | JPMORGAN CHASE & CO | 246,400 | $90.0M | 0.0% | 0.2% | +30.8% |
| 22 | Driehaus Capital Management LLC | 240,589 | $88.0M | 0.6% | 0.2% | +577.6% |
| 23 | UBS Group AG | 233,620 | $85.5M | 0.0% | 0.2% | -9.7% |
| 24 | CAPITAL INTERNATIONAL SARL | 206,194 | $75.5M | 1.0% | 0.2% | +17.5% |
| 25 | Temasek Holdings (Private) Ltd | 205,466 | $75.2M | 0.2% | 0.2% | -75.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.